Azamian Bobak R.
SEC insider (Form 3/4/5 filer). CIK 0001827672. President/CEO and Board Chair at Tarsus Pharmaceuticals, Inc. (TARS). 23 reported Form 4/5 transactions since Sep 2024; latest on Sep 4, 2026. Located in IRVINE, CA.
Companies Azamian Bobak R. has filed insider reports for
- Tarsus Pharmaceuticals, Inc. (TARS): Director, Officer, President/CEO and Board Chair
Azamian Bobak R.
CIK: 0001827672
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Tarsus Pharmaceuticals, Inc.
Discretionary Trading P&L
Holdings
Transaction History (23 total)
- Sep 4, 2026TARS
Tarsus Pharmaceuticals, Inc.
SaleIndirect2.9K shares at avg. $91.27$265K - Sep 4, 2026TARS
Tarsus Pharmaceuticals, Inc.
SaleIndirect7.1K shares at avg. $90.27$641K - Sep 2, 2026TARS
Tarsus Pharmaceuticals, Inc.
SaleIndirect10K shares at avg. $80.06$801K - Jun 17, 2026TARS
Tarsus Pharmaceuticals, Inc.
SaleIndirect5.4K shares at avg. $61.81$335K - Jun 17, 2026TARS
Tarsus Pharmaceuticals, Inc.
SaleIndirect4.6K shares at avg. $61.24$281K - Mar 19, 2026TARS
Tarsus Pharmaceuticals, Inc.
SaleDirect12K shares at avg. $67.00$802K - Mar 18, 2026TARS
Tarsus Pharmaceuticals, Inc.
SaleDirect11.7K shares at avg. $68.71$802K - Mar 17, 2026TARS
Tarsus Pharmaceuticals, Inc.
SaleDirect11K shares at avg. $69.42$762K - Mar 15, 2026TARS
Tarsus Pharmaceuticals, Inc.
ExerciseDirect66.3K shares- - Mar 5, 2026TARS
Tarsus Pharmaceuticals, Inc.
AwardDirectStock Option (right to buy)
96.7K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 4, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Sale | 2,900 | $91.27 | $264,683 | Indirect |
| Sep 4, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Sale | 7,100 | $90.27 | $640,917 | Indirect |
| Sep 2, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Sale | 10,000 | $80.06 | $800,600 | Indirect |
| Jun 17, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Sale | 5,418 | $61.81 | $334,887 | Indirect |
| Jun 17, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Sale | 4,582 | $61.24 | $280,602 | Indirect |
| Mar 19, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Sale | 11,964 | $67.00 | $801,588 | Direct |
| Mar 18, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Sale | 11,667 | $68.71 | $801,640 | Direct |
| Mar 17, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Sale | 10,972 | $69.42 | $761,676 | Direct |
| Mar 15, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Exercise | 66,274 | - | $0 | Direct |
| Mar 5, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Award Stock Option (right to buy) | 96,723 | - | - | Direct |
1-10 of 23 transactions